| Title : Severe hypertriglyceridemia: Existing and emerging therapies - Malick_2023_Pharmacol.Ther__108544 |
| Author(s) : Malick WA , Do R , Rosenson RS |
| Ref : Pharmacol Ther , :108544 , 2023 |
| Abstract : |
| PubMedSearch : Malick_2023_Pharmacol.Ther__108544 |
| PubMedID: 37848164 |
| Title : Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial - Rosenson_2023_Nat.Med__ |
| Author(s) : Rosenson RS , Gaudet D , Ballantyne CM , Baum SJ , Bergeron J , Kershaw EE , Moriarty PM , Rubba P , Whitcomb DC , Banerjee P , Gewitz A , Gonzaga-Jauregui C , McGinniss J , Ponda MP , Pordy R , Zhao J , Rader DJ |
| Ref : Nat Med , : , 2023 |
| Abstract : |
| PubMedSearch : Rosenson_2023_Nat.Med__ |
| PubMedID: 36879129 |
| Gene_locus related to this paper: human-LPL |
| Title : Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2 - Rosenson_2012_J.Lipid.Res_53_1767 |
| Author(s) : Rosenson RS , Stafforini DM |
| Ref : J Lipid Res , 53 :1767 , 2012 |
| Abstract : |
| PubMedSearch : Rosenson_2012_J.Lipid.Res_53_1767 |
| PubMedID: 22665167 |